Skip to main content

Psychedelic Compounds-Based Drug Stocks Down Slightly This Past Week

We're tracking 13 public companies (US and/or Canada) doing clinical-stage research into THC and/or psychedelics for treating mental illnesses. While a few were up this week, the overall trend continues downward.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.